Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain

Phase 4

Completed

• Conditions: Postoperative Pain
• Interventions: Drug: Fentanyl transdermal patch

• Registration Number: NCT03199157
• Lead Sponsor: Baskent University

Brief Summary

The investigators designed a prospective randomized study to investigate the effect of fentanyl 12 mcg transdermal patch on postoperative pain following unilateral, single-level laminectomy/discectomy.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03
• Primary Completion: 2016-09
• Study Completion: 2016-12
• Status Verified: 2017-06
• Study First Submitted: 2017-06-23
• Study First Submitted QC: 2017-06-23
• Last Update Submitted: 2017-06-23
• Study First Posted: 2017-06-26
• Last Update Posted: 2017-06-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

• Patients between the ages of 20-70 years
• ASA physical status 1-2 patients undergoing single-level laminectomy/discectomy

Exclusion Criteria

• A history of allergy to any study drugs
• History of opioid use, obstructive sleep apnea
• Any psychological disorders
• hepatic or renal failure

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Fentanyl Group	Fentanyl transdermal patch	Patients received the fentanyl 12 mcg transdermal patch (FG, n=38) 8 hours preoperatively and until 24 hours after the surgery

Primary Outcome Measures

Name	Time	Method
Numeric rating score for pain (NRS)	Postoperative 24 hours